![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Trends in and factors associated with virological failure among women conceiving on cART in Western Europe
|
|
|
Reported by Jules Levin
CROI 2013
H Bailey, C L Townsend, M Cortina-Borja and C Thorne for the European Collaborative Study in EuroCoord
UCL Institute of Child Health, University College London
![CROI1.gif](../images/031813/031813-1/CROI1.gif)
- 19% (74/396) of women had virological failure, with a median viral load of 1370 copies/ml (IQR 480, 6000).
- The proportion with virological failure declined ten-fold from 34% (32/93) in 2000-01 to 3% (1/33) in 2010-11 (trend p<0.01, Figure 1); 64 of the 74 women with virological failure enrolled prior to 2006.
- Median age 33 yrs; 56% from sub-saharan Africa, 33% had CD4 <350
- 37% of women were on a non-nucleoside reverse transcriptase inhibitor (NNRTI)-based regimen (mostly nevirapine);
![CROI2.gif](../images/031813/031813-1/CROI2.gif)
![CROI3.gif](../images/031813/031813-1/CROI3.gif)
![CROI4.gif](../images/031813/031813-1/CROI4.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|